Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial

Jonathan Rabinowitz, Stefan Badescu, Pavel Palamarchuk, Viktor Filyk, Anatolii Voloshchuk, Vadym Rud, Ellina Melnyk, Andrii Skrypnikov, Michael Davidson, Jay Saoud, Remy Luthringer

Research output: Contribution to journalLetterpeer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)103-104
Number of pages2
JournalSchizophrenia Research
StatePublished - Sep 2019

Bibliographical note

Funding Information:
The study phase 2b clinical trial was funded by Minerva Neurosciences.

Cite this